We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

STT:NYSEState Street Corporation Analysis

Data as of 2026-03-10 - not real-time

$121.93

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

State Street Corp (STT) is trading at $121.93, well below its DCF fair value of $883 and an 18% upside potential, while its P/E of ~13 is comfortably under the industry average of 17.4, indicating a sizable valuation gap. Technical signals are mixed: the price sits beneath the 20‑day SMA (128.04) and 50‑day SMA (129.67), the RSI is at 39 suggesting modest oversold pressure, and a bearish MACD histogram reinforces short‑term downside bias. However, the 200‑day SMA (116.51) is below the current price, hinting that the longer‑term trend remains intact. Fundamentally, STT delivers solid earnings with a trailing EPS of $9.40, operating margin of 34%, and revenue growth of 7.6% YoY, supported by a massive cash pile of $143 B versus $55.9 B of debt, resulting in a zero‑debt‑to‑equity ratio. The dividend yield of 2.76% and a modest 34% payout ratio underscore dividend sustainability, while a beta around 1.1‑1.4 and 30% 30‑day volatility signal heightened market sensitivity. Recent material news highlights a new quarterly dividend declaration and a strategic partnership with Neudata to expand data services, reinforcing the company’s focus on growth and client‑centric innovation. Overall, the stock presents a compelling blend of value and growth attributes, with upside potential tempered by short‑term technical weakness.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below 20‑day and 50‑day SMAs
  • Bearish MACD histogram
  • RSI indicating near‑oversold condition

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative to DCF and peers
  • Strong cash position and low debt
  • Attractive dividend yield with sustainable payout

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Durable asset‑management franchise
  • Consistent revenue growth and operating margins
  • Strategic data partnership expanding service offerings

Key Metrics & Analysis

Financial Health

Revenue Growth7.60%
Profit Margin21.21%
P/E Ratio13.0
ROE11.08%
ROA0.82%
P/B Ratio1.4
Op. Cash Flow$11.9B
Industry P/E17.4

Technical Analysis

TrendNeutral
RSI39.0
Support$116.15
Resistance$135.36
MA 20$128.04
MA 50$129.67
MA 200$116.51
MACDBearish
VolumeIncreasing
Fear & Greed Index77.07

Valuation

Fair Value$883.27
Target Price$144.30
Upside/Downside18.35%
GradeUndervalued
TypeBlend
Dividend Yield2.76%

Risk Assessment

Beta1.14
Volatility30.28%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.